ENLIVEN THERAPEUTICS INC (ELVN)
US29337E1029 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -71.58M | 1.49M | -51.38M | -41.36M | -23.48M | |||
| Depreciation Amortization | 297.00K | 610.00K | 100.00K | 100.00K | 30.00K | |||
| Change In Working Capital | 1.40M | -5.36M | 510.00K | 1.51M | 670.00K | |||
| Other non cash items | 8.62M | -32.31M | 4.00M | 2.35M | 900.00K | |||
| OPERATING CASH FLOW | -61.27M | -35.57M | -46.77M | -37.40M | -21.88M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -149.00K | -360.00K | -10.00K | -20.00K | -140.00K | |||
| Other Investing Activity | -148.26M | 76.88M | -1.62M | -16.70M | -23.92M | |||
| INVESTING CASH FLOW | -148.41M | 76.52M | -1.63M | -16.72M | -24.06M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 399.00K | 0.00 | 49.68M | 98.60M | 45.58M | |||
| Other Financing Activity | 233.89M | -1.23M | -580.00K | -1.72M | -2.00M | |||
| FINANCING CASH FLOW | 234.29M | -1.23M | 49.10M | 96.88M | 43.58M | |||
| CHANGE IN CASH | 24.60M | 39.72M | 700.00K | 42.76M | -2.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -61.27M | -35.57M | -46.77M | -37.40M | -21.88M | |||
| Capital Expenditure | -149.00K | -360.00K | -10.00K | -20.00K | -140.00K | |||
| FREE CASH FLOW | -61.42M | -35.93M | -46.78M | -37.42M | -22.02M | |||
All data in USD